Pharma Journalist 8947 posts 0 comments

Boehringer Ingelheim and Yuhan Corporation announced a collaboration and license agreement for the development of a first-in-class dual agonist for the treatment of NASH and related…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of the privately held clinical-stage biotechnology company Therachon Holding AG. Under the terms of the transaction,…
Read More...

Real World Evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real-world into their development programs, drug developers…
Read More...

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company announced a new Peptide Drug Conjugate “PDC” collaboration agreement with Swiss-based Novartis. Under the agreement,…
Read More...

Aucta Pharmaceuticals announced that the Company has entered into an agreement with Eton Pharmaceuticals, Inc. to License U.S. marketing rights for AUC025. AUC025 is an innovative…
Read More...

ContraVir Pharmaceuticals, a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis…
Read More...

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a €3 million Series B financing round to advance its functional…
Read More...

SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced to launch Bivalirudin…
Read More...

Sartorius Stedim Biotech (SSB) launched a new vessel for its ambr 250 modular benchtop automated mini bioreactor system. The single-use vessel has been specially designed for…
Read More...

SMi Reports: Alexion Pharmaceuticals and Minoryx Therapeutics to deliver presentations at the 9th Annual Orphan Drugs and Rare Diseases Conference The orphan drugs market recently…
Read More...